Profil
Cédric Bisson is currently the Chairman at Procure and the Director at Iaculor Injection, Inc. He also holds the position of Director at Grand Challenges Canada, Northern Biologics, Inc., 35Pharma, Inc., and Associate at Teralys Capital, Inc. In the past, Dr. Bisson worked as a Director at Milestone Pharmaceuticals, Inc. and Mimetogen Pharmaceuticals, Inc. He was also the Managing Partner at iNovia Capital, Inc. from 2003 to 2010 and an Associate Principal at McKinsey & Co., Inc. (Canada).
Dr. Bisson holds a doctorate degree from McGill University and a graduate degree from the University of Montréal.
Aktive Positionen von Cédric Bisson
| Unternehmen | Position | Beginn |
|---|---|---|
Teralys Capital, Inc.
 Teralys Capital, Inc. Investment ManagersFinance Teralys Capital, Inc (Teralys) is private equity/venture capital firm founded in 2009 by Jacques Bernier and Eric Legault. The firm is headquartered in Canada. | Private Equity Investor | 01.09.2011 |
| Procure | Vorsitzender | - |
Grand Challenges Canada
 Grand Challenges Canada Medical/Nursing ServicesHealth Services Grand Challenges Canada provides support services for healthcare. It specializes in global health, innovation, global mental health, international development, impact investing, maternal, newborn and child health, and research and development. The company was founded in May 2010 is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | 04.05.2016 |
Iaculor Injection, Inc.
 Iaculor Injection, Inc. Medical SpecialtiesHealth Technology Iaculor Injection, Inc. develops needle free medical devices. It engages in the development and commercialization of needle-free medical devices for injecting drugs and vaccines. The company was founded by Martin Brouillette and is headquartered in Sherbrooke, Canada. | Direktor/Vorstandsmitglied | - |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - |
35Pharma, Inc.
 35Pharma, Inc. Pharmaceuticals: MajorHealth Technology 35Pharma, Inc. designs and develops biologics for diseases of high unmet medical need. The CEO of the Canadian company is Ilia A. Tikhomirov. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Cédric Bisson
| Unternehmen | Position | Ende |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 05.03.2012 |
iNovia Capital, Inc.
 iNovia Capital, Inc. Investment ManagersFinance iNovia Capital, Inc., formerly MSBi Capital, is a venture capital firm founded in 2001 by Shawn Abbott. The firm is headquarters in Montreal Canada. | Private Equity Investor | 22.12.2010 |
McKinsey & Co., Inc. (Canada)
 McKinsey & Co., Inc. (Canada) Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. (Canada) provides management consulting services for private, public, and social sector institutions. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Cédric Bisson
| McGill University | Doctorate Degree |
| University of Montréal | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
iNovia Capital, Inc.
iNovia Capital, Inc. Investment ManagersFinance iNovia Capital, Inc., formerly MSBi Capital, is a venture capital firm founded in 2001 by Shawn Abbott. The firm is headquarters in Montreal Canada. | Finance |
Mimetogen Pharmaceuticals, Inc.
 Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Health Technology |
Teralys Capital, Inc.
Teralys Capital, Inc. Investment ManagersFinance Teralys Capital, Inc (Teralys) is private equity/venture capital firm founded in 2009 by Jacques Bernier and Eric Legault. The firm is headquartered in Canada. | Finance |
| Procure | |
McKinsey & Co., Inc. (Canada)
McKinsey & Co., Inc. (Canada) Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. (Canada) provides management consulting services for private, public, and social sector institutions. The company is headquartered in Toronto, Canada. | Commercial Services |
Grand Challenges Canada
Grand Challenges Canada Medical/Nursing ServicesHealth Services Grand Challenges Canada provides support services for healthcare. It specializes in global health, innovation, global mental health, international development, impact investing, maternal, newborn and child health, and research and development. The company was founded in May 2010 is headquartered in Toronto, Canada. | Health Services |
Iaculor Injection, Inc.
Iaculor Injection, Inc. Medical SpecialtiesHealth Technology Iaculor Injection, Inc. develops needle free medical devices. It engages in the development and commercialization of needle-free medical devices for injecting drugs and vaccines. The company was founded by Martin Brouillette and is headquartered in Sherbrooke, Canada. | Health Technology |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Health Services |
35Pharma, Inc.
35Pharma, Inc. Pharmaceuticals: MajorHealth Technology 35Pharma, Inc. designs and develops biologics for diseases of high unmet medical need. The CEO of the Canadian company is Ilia A. Tikhomirov. | Health Technology |
